PARMAR KUSH
CIK 1664281
Transactions on file
36
Open-market buys
1
Win rate (buys)
100%
1 scored
Avg % since filing (buys)
+151.0%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-24 | 2026-09-23 | SKYE Skye Bioscience, Inc. | 10% | Sale | 4,528 | $7.3K | +3.7% | open → |
| 2026-09-24 | 2026-09-23 | SKYE Skye Bioscience, Inc. | 10% | Sale | 114,851 | $184.9K | +3.7% | open → |
| 2026-09-24 | 2026-09-22 | SKYE Skye Bioscience, Inc. | 10% | Sale | 1,088 | $1.8K | +1.2% | open → |
| 2026-09-24 | 2026-09-22 | SKYE Skye Bioscience, Inc. | 10% | Sale | 27,612 | $45.6K | +1.2% | open → |
| 2026-09-18 | 2026-09-16 | SKYE Skye Bioscience, Inc. | 10% | Sale | 1,285 | $2.5K | -12.6% | open → |
| 2026-09-18 | 2026-09-16 | SKYE Skye Bioscience, Inc. | 10% | Sale | 32,607 | $62.3K | -12.6% | open → |
| 2026-08-21 | 2026-08-20 | SKYE Skye Bioscience, Inc. | 10% | Sale | 6,495 | $2.1K | +421.9% | open → |
| 2026-08-21 | 2026-08-20 | SKYE Skye Bioscience, Inc. | 10% | Sale | 46 | $14.72 | +421.9% | open → |
| 2026-08-21 | 2026-08-20 | SKYE Skye Bioscience, Inc. | 10% | Sale | 1,159 | $370.88 | +421.9% | open → |
| 2026-08-21 | 2026-08-19 | SKYE Skye Bioscience, Inc. | 10% | Sale | 57,476 | $20.1K | +377.1% | open → |
| 2026-08-21 | 2026-08-19 | SKYE Skye Bioscience, Inc. | 10% | Sale | 409 | $143.15 | +377.1% | open → |
| 2026-08-21 | 2026-08-19 | SKYE Skye Bioscience, Inc. | 10% | Sale | 10,255 | $3.6K | +377.1% | open → |
| 2026-08-21 | 2026-08-18 | SKYE Skye Bioscience, Inc. | 10% | Sale | 253,080 | $96.2K | +339.5% | open → |
| 2026-08-21 | 2026-08-18 | SKYE Skye Bioscience, Inc. | 10% | Sale | 1,830 | $695.40 | +339.5% | open → |
| 2026-08-21 | 2026-08-18 | SKYE Skye Bioscience, Inc. | 10% | Sale | 45,090 | $17.1K | +339.5% | open → |
| 2026-08-12 | 2026-08-10 | LTGO Latigo Biotherapeutics, Inc. | 10% | C | 2,350,419 | $0.00 | — | open → |
| 2026-08-12 | 2026-08-10 | LTGO Latigo Biotherapeutics, Inc. | 10% | C | 4,975,543 | $0.00 | — | open → |
| 2026-08-10 | 2026-08-10 | TRDA Entrada Therapeutics, Inc. | Sale | 92,444 | $647.1K | -11.1% | open → | |
| 2026-08-10 | 2026-08-07 | TRDA Entrada Therapeutics, Inc. | Sale | 52,317 | $358.4K | -9.2% | open → | |
| 2026-08-10 | 2026-08-06 | TRDA Entrada Therapeutics, Inc. | Sale | 10,494 | $73.5K | -11.1% | open → | |
| 2026-08-03 | 2026-07-31 | TRDA Entrada Therapeutics, Inc. | Sale | 1,718 | $11.8K | -9.2% | open → | |
| 2026-08-03 | 2026-07-30 | TRDA Entrada Therapeutics, Inc. | Sale | 114,756 | $795.3K | -10.2% | open → | |
| 2025-11-18 | 2025-11-14 | TRDA Entrada Therapeutics, Inc. | Sale | 200,000 | $1.76M | -29.3% | open → | |
| 2025-07-01 | 2025-06-27 | TRDA Entrada Therapeutics, Inc. | Director10% | Sale | 55,735 | $385.1K | -10.0% | open → |
| 2025-07-01 | 2025-06-30 | TRDA Entrada Therapeutics, Inc. | Director10% | Sale | 18,578 | $126.5K | -8.7% | open → |
| 2025-07-01 | 2025-06-30 | TRDA Entrada Therapeutics, Inc. | Director10% | Sale | 6,422 | $43.7K | -8.7% | open → |
| 2025-07-01 | 2025-07-01 | TRDA Entrada Therapeutics, Inc. | Director10% | Sale | 18,578 | $132.3K | -12.6% | open → |
| 2025-07-01 | 2025-07-01 | TRDA Entrada Therapeutics, Inc. | Director10% | Sale | 6,422 | $45.7K | -12.6% | open → |
| 2025-07-01 | 2025-06-27 | TRDA Entrada Therapeutics, Inc. | Director10% | Sale | 19,265 | $133.1K | -10.0% | open → |
| 2025-07-11 | 2025-07-09 | TRDA Entrada Therapeutics, Inc. | Director10% | Sale | 6,935 | $52.0K | -17.1% | open → |
| 2025-07-11 | 2025-07-09 | TRDA Entrada Therapeutics, Inc. | Director10% | Sale | 20,065 | $150.5K | -17.1% | open → |
| 2025-08-22 | 2025-08-21 | SKYE Skye Bioscience, Inc. | 10% | Sale | 2,314 | $8.3K | -53.2% | open → |
| 2025-08-22 | 2025-08-22 | SKYE Skye Bioscience, Inc. | 10% | Sale | 163,979 | $560.8K | -51.2% | open → |
| 2025-08-22 | 2025-08-22 | SKYE Skye Bioscience, Inc. | 10% | Sale | 6,470 | $22.1K | -51.2% | open → |
| 2025-08-22 | 2025-08-21 | SKYE Skye Bioscience, Inc. | 10% | Sale | 58,642 | $209.4K | -53.2% | open → |
| 2025-09-15 | 2025-09-11 | CAMP Camp4 Therapeutics Corp | 10% | Buy | 2,941,176 | $4.50M | +151.0% | open → |
